Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Prostatic Neoplasms 31Testicular Neoplasms 4Breast Neoplasms 4Vomiting 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma 3Carcinoma, Transitional Cell 3Urinary Bladder Neoplasms 2Testicular Germ Cell Tumor 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms 2Nausea 2Myeloproliferative Disorders 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Filgrastim 10Carboplatin 10Ifosfamide 9Paclitaxel 8Peripheral Blood Stem Cell Transplantation 7Etoposide 7X-Rays 5Specimen Handling 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Thiotepa 4Nuclear Medicine Department, Hospital 4Melphalan 4Cisplatin 4Busulfan 4Biopsy 4pegfilgrastim 3etoposide phosphate 3Temozolomide 3Granulocyte Colony-Stimulating Factor 3tazemetostat 2olaparib 2larotrectinib 2ixabepilone 2erdafitinib 2ensartinib 2Vemurafenib 2Stem Cell Transplantation 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Dexamethasone × Genitourinary × Clear all
NCT01172912 2013-08-12

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
CNSGenitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡